INTELLIGENT BIO SOLUTIONS INC.
INBSNasdaq
$2.11
↓ -4.0%Jul 17 close · end-of-day
Price
1Y↓ -90.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3.4M
Enterprise Value
-$3.5M
P/E
0.7
P/S
1.0
P/B
0.4
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$3.5M
Net Income (TTM)
-$11.6M
Free Cash Flow (TTM)
—
Gross Margin
53.1%
Operating Margin
-335.5%
Net Margin
-333.7%
ROE
-129.6%
ROIC
-439.4%
Debt / Equity
—
Net Cash
$6.9M
Return 1Y
-90.1%
Company profile
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company was incorporated in 2016 and is headquartered in New York, New York.
- CEO
- Harry Simeonidis
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 10
- Headquarters
- New York
- Website
- gbs.inc
Management & directors
- Sakiris Spiro KevinChief Financial Officer
- Simeonidis HarryChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
INBS Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.1M↑ +17.6%
Diluted EPS-$1.80↓ -59.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.0M | $437,146.00 | $1.3M | $3.1M | $3.1M |
| Gross profit | — | — | $326,668.00 | $1.4M | $1.2M |
| Operating income | -$5.6M | -$8.3M | -$12.6M | -$10.3M | -$10.6M |
| Net income | -$7.0M | -$8.3M | -$10.6M | -$10.2M | -$10.6M |
| Diluted EPS | — | -$11.33 | -$127.00 | -$6.38 | -$2.00 |
| Operating cash flow | -$11.3M | -$3.4M | -$7.4M | -$9.6M | -$9.7M |
| Free cash flow | — | — | — | -$9.8M | -$9.9M |
| Gross margin | — | — | 26.0% | 45.8% | 40.8% |
| Operating margin | -281.4% | -1907.1% | -1002.1% | -330.5% | -348.7% |
| Net margin | -355.3% | -1900.1% | -845.9% | -326.4% | -346.2% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $380,907.00 | $998,415.00 | $741,134.00 | $902,138.00 | $410,845.00 | $1.1M | $896,774.00 | $1.1M |
| Gross profit | $815,558.00 | $346,801.00 | $223,113.00 | $341,368.00 | $335,577.00 | $518,291.00 | $459,739.00 | $535,381.00 |
| Operating income | -$2.8M | -$2.7M | -$2.3M | -$2.6M | -$3.1M | -$3.0M | -$2.6M | -$2.9M |
| Net income | -$2.8M | -$2.7M | -$2.2M | -$2.5M | -$3.1M | -$3.0M | -$2.7M | -$2.9M |
| Diluted EPS | $9.60 | -$0.70 | -$4.96 | -$4.41 | $8.07 | -$0.35 | -$2.82 | -$1.80 |
| Operating cash flow | -$2.9M | -$2.4M | -$2.3M | -$2.8M | -$2.2M | -$2.8M | -$1.6M | -$4.3M |
| Free cash flow | — | — | — | — | — | -$2.9M | -$1.6M | -$4.3M |
| Gross margin | 214.1% | 34.7% | 30.1% | 37.8% | 81.7% | 46.6% | 51.3% | 50.5% |
| Operating margin | -738.2% | -273.0% | -305.5% | -283.8% | -753.2% | -269.8% | -293.9% | -277.8% |
| Net margin | -731.0% | -269.0% | -303.5% | -281.9% | -752.1% | -268.3% | -298.6% | -269.9% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-18 | Boyages Steven Constantine | Award | 5,000 | $0.00 | $0.00 | filing |
| 2026-03-18 | Fraser Nicola Marion | Award | 5,000 | $0.00 | $0.00 | filing |
| 2026-03-18 | Sakiris Spiro Kevin· Chief Financial Officer | Award | 9,150 | $0.00 | $0.00 | filing |
| 2026-03-18 | Sakiris Spiro Kevin· Chief Financial Officer | Award | 21,350 | $0.00 | $0.00 | filing |
| 2026-03-18 | Hurd Jonathan Scott | Award | 5,000 | $0.00 | $0.00 | filing |
| 2026-03-18 | Isenberg Jason | Award | 5,000 | $0.00 | $0.00 | filing |
| 2026-03-18 | Simeonidis Harry· Chief Executive Officer | Award | 9,150 | $0.00 | $0.00 | filing |
| 2026-03-18 | Simeonidis Harry· Chief Executive Officer | Award | 21,350 | $0.00 | $0.00 | filing |
Latest 8 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.